United States· US:61874-075_772a8af8-21e9-46bb-af21-34365ae0c477
Viberzi
A eluxadoline product containing eluxadoline, registered in United States by Allergan, Inc.. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Eluxadoline is registered in 5 of 19 countries.
Countries holding a registration under ATC A07DA06 (eluxadoline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Eluxadoline · ATC A07DA06
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eluxadoline costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- United States: $65.57 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Eluxadoline · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- US United States$65.57 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Eluxadoline
- Manufacturer
- Allergan, Inc.
- Country
- United States (US)
- ATC code
- A07DA06
- ATC class
- Eluxadoline
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 3
- ndc1161874075081 BLISTER PACK in 1 CARTON (61874-075-08) / 8 TABLET, FILM COATED in 1 BLISTER PACK
- ndc1161874075161 BLISTER PACK in 1 CARTON (61874-075-16) / 16 TABLET, FILM COATED in 1 BLISTER PACK
- ndc1161874075601 BOTTLE in 1 CARTON (61874-075-60) / 60 TABLET, FILM COATED in 1 BOTTLE
Regulatory notes
Interactions
244 interactions on record for eluxadoline.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eluxadoline · interactions on record
244 records
- 25 severe
- 218 moderate
- 1 minor
Most severe, free to view
- EltrombopagB02BX05severe
- EthanolB05XX04severe
- GemfibrozilC10AB04severe
- RifampicinJ04AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eluxadoline in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f82d4f5-fbd5-44b8-a0ca-bcd290b86476 GET /v1/drugs/8f82d4f5-fbd5-44b8-a0ca-bcd290b86476?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "45TPJ4MBQ1",
"rxcui": "1653781",
"inchikey": "QFNHIDANIVGXPE-FNZWTVRRSA-N",
"display_name": "ELUXADOLINE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 3
},
"spl_meta": {
"7821bd40-4c84-4984-951b-6436ae20421a": {
"match": "brand_token",
"title": "VIBERZI (ELUXADOLINE) TABLET, FILM COATED [ALLERGAN, INC.]",
"spl_version": "27",
"published_date": "2026-04-20"
}
},
"productid": "61874-075_772a8af8-21e9-46bb-af21-34365ae0c477",
"productndc": "61874-075",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "206940",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "75MG",
"product_no": "001",
"approval_date": "May 27, 2015"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "100MG",
"product_no": "002",
"approval_date": "May 27, 2015"
}
],
"appl_type": "N"
},
"dea_schedule": "CIV",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ELUXADOLINE",
"proprietary_name": "Viberzi",
"active_ingred_unit": "mg/1",
"application_number": "NDA206940",
"marketing_category": "NDA",
"nonproprietary_name": "Eluxadoline",
"start_marketing_date": "20151001",
"active_numerator_strength": "75"
}See everything about eluxadoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.